Abstract
Purpose
To evaluate the relation between CD34+ cells count in maternal blood and potential development of fetal congenital renal abnormalities.
Materials and methods
We enrolled 16 women that gave birth to newborns carrying congenital renal malformations over a 3-year period and 48 women with uncomplicated pregnancies (controls) in a 1:3 ratio (three controls per case).
Results
CD34+ cells in the maternal peripheral blood were significantly lower in the group of women who gave birth to newborns carrying congenital renal malformations compared to the controls (p < .0001).
Conclusions
CD34+ cells in maternal blood could be validated as a potential marker to predict the development of possible kidney malformations.
Disclosure statement
No potential conflict of interest was reported by the authors.